by Hamideh Emrani | Oct 25, 2016
This year’s Till & McCulloch Meetings (TMM2016) began with a diverse set of topics organized into three different plenary sessions. The first session, on regulatory networks in stem cells, began with Sara-Jane Dunn from Microsoft Research who introduced us to “The...
by Holly Wobma | Oct 18, 2016
I have a confession. This is not a blog about stem cells. It is, however, a blog about cells with infinite possibilities of fate. Because we are entering the world of synthetic biology, where crafty cellular engineering has enabled a new level of control over immune...
by Holly Wobma | Sep 22, 2016
If you have been following stem cell news lately, you know that there have been several recent Food and Drug Administration (FDA) meetings regarding how to classify stem cells, which ultimately affects if and how they will be regulated. There are many medical...
by Michael May | Aug 30, 2016
Michael May is President and CEO of CCRM, a leader in developing and commercializing regenerative medicine, cell and gene therapy technologies, Michael Rudnicki is Scientific Director and CEO of Stem Cell Network, with a mandate to translate stem cell research into...
by Holly Wobma | Aug 29, 2016
As humans, it is natural to categorize our environment. Usually, these groups include perceptible differences. -The red shirt vs. the blue shirt (not the near infrared vs. far infrared shirt) -The quiet (to our ears) sound vs. the loud sound -etc. Since we don’t...
by Jovana Drinjakovic | Aug 25, 2016
Science fiction became real life in September 2014, when a team of eye surgeons in Japan transplanted a body part, grown entirely in a dish, into the eye of a patient suffering from an eye disease. The retinal graft came from the patient’s skin cells, raising hopes...
Comments